MK

Mukkala Keerthi Sai

Active Director Director DIN 11379377
DIN 11379377 First appointment Nov 2025
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value •••• Premium profile

About Mukkala Keerthi Sai

Data last updated:

Mukkala Keerthi Sai is a Director at Celestum Biotech Private Limited (since 2025). Celestum Biotech Private Limited reported revenue of ₹12.5 Lakh (FY 2025).

DIN 11379377
Primary Designation Director
First Appointment 30 Nov 2025
Oldest Company Age 3 yrs
Largest company Celestum Biotech Private Limited · ₹12.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Celestum Biotech Private Limited U01619PN2023PTC219391
Director30 Nov 20252023₹12.5 Lakh (FY 2025)Active

Board colleagues of Mukkala Keerthi Sai

NameDINCompanyDesignation
Mahitha Kodali10109746Celestum Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Celestum Biotech Private Limited
Premium access

Shareholding and investment profile for Mukkala Keerthi Sai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukkala Keerthi Sai

Mukkala Keerthi Sai currently holds 1 directorship: Celestum Biotech Private Limited (Director, since 30 Nov 2025, revenue ₹12.5 Lakh (FY 2025)).

Mukkala Keerthi Sai was first appointed on 30 Nov 2025 as Director at Celestum Biotech Private Limited.

The current boards of Mukkala Keerthi Sai's companies include Mahitha Kodali (Celestum Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available